Friday, January 17, 2025 6:53:34 AM
and it should go in Elites favor for (obvious) reasons.
my next guess
The Judge sends a CC copy to each party concerned then a CC to the FDA, then the FDA guys send it to their lawyers They
have to sign off, then they send it back to the FDA guys, then the FDA sends the approval to Elite, then Elite can start making
generic Oxycontin,,
simple as that
badda bing badda boom
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/23/2025 11:05:31 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/16/2025 11:05:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2025 08:40:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2025 12:10:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2025 09:56:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2025 09:05:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2024 09:20:18 PM
One World Products (to become Isiah Enterprises) Targets December Operational Breakeven; 250,000+ Pounds of Pelletized Rubber Shipped • OWPC • Dec 10, 2025 11:24 AM
Growing Momentum Signals Opportunity as Explorers Shift Toward Production, Reveal Substantial Value • LFLRF • Dec 10, 2025 9:00 AM
Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • BLEG • Dec 10, 2025 9:00 AM
Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing • BLO • Dec 9, 2025 8:45 AM
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival • AVAI • Dec 9, 2025 8:00 AM
Momentum Builds, Upside Appears as Mining Explorers Transition Toward Production, Unlock Major Hidden Value • B • Dec 8, 2025 9:00 AM
